Hemodynamic effects of supplemental oxygen administration in congestive heart failure. 1996

W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
Division of Cardiology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania, USA.

OBJECTIVE This study sought to determine the hemodynamic effects of oxygen therapy in heart failure. BACKGROUND High dose oxygen has detrimental hemodynamic effects in normal subjects, yet oxygen is a common therapy for heart failure. Whether oxygen alters hemodynamic variables in heart failure is unknown. METHODS We studied 10 patients with New York Heart Association functional class III and IV congestive heart failure who inhaled room air and 100% oxygen for 20 min. Variables measured included cardiac output, stroke volume, pulmonary capillary wedge pressure, systemic and pulmonary vascular resistance, mean arterial pressure and heart rate. Graded oxygen concentrations were also studied (room air, 24%, 40% and 100% oxygen, respectively; n = 7). In five separate patients, muscle sympathetic nerve activity and ventilation were measured during 100% oxygen. RESULTS The 100% oxygen reduced cardiac output (from 3.7 +/- 0.3 to 3.1 +/- 0.4 liters/min [mean +/- SE], p < 0.01) and stroke volume (from 46 +/- 4 to 38 +/- 5 ml/beat per min, p < 0.01) and increased pulmonary capillary wedge pressure (from 25 +/- 2 to 29 +/- 3 mm Hg, p < 0.05) and systemic vascular resistance (from 1,628 +/- 154 to 2,203 +/- 199 dynes.s/cm5, p < 0.01). Graded oxygen led to a progressive decline in cardiac output (one-way analysis of variance, p < 0.0001) and stroke volume (p < 0.017) and an increase in systemic vascular resistance (p < 0.005). The 100% oxygen did not alter sympathetic activity or ventilation. CONCLUSIONS In heart failure, oxygen has a detrimental effect on cardiac output, stroke volume, pulmonary capillary wedge pressure and systemic vascular resistance. These changes are independent of sympathetic activity and ventilation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010102 Oxygen Inhalation Therapy Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed) Inhalation Therapy, Oxygen,Therapy, Oxygen Inhalation,Inhalation Therapies, Oxygen,Oxygen Inhalation Therapies,Therapies, Oxygen Inhalation
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
November 1996, Journal of the American College of Cardiology,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
March 1989, The American journal of cardiology,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
September 1980, The American journal of cardiology,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
August 1987, Cardiovascular drugs and therapy,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
June 1993, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
December 1988, The American journal of the medical sciences,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
July 1986, Japanese circulation journal,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
September 1993, American heart journal,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
January 1985, Journal of cardiovascular pharmacology,
W A Haque, and J Boehmer, and B S Clemson, and U A Leuenberger, and D H Silber, and L I Sinoway
June 1990, The American journal of cardiology,
Copied contents to your clipboard!